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We presented a case of Wolff-Parkinson-White (WPW) Syndrome. A 69-year-old man was admitted for 
evaluation of frequent episodes of palpitation. The diagnosis of WPW syndrome was established based on the 
12-lead surface electrocardiogram (ECG) and electrophysiology (EP) study. We conducted the radiofrequency 
ablation (RFA) to the accessory pathway (AP). The challenging point of this case was the accessory pathway 
located just below to the bundle of His, which is related to the risk of complete atrioventricular (AV) block. In 
summary, we conclude that anatomical consideration, EP study, and the ablation strategy were important to 
improve the safety and success rate of RFA procedure.
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 The Wolff-Parkinson-White (WPW) syndrome is a type of 
pre-excitation syndrome in which part of the ventricle is depolarized 
earlier by the accessory pathway (AP) that bypasses the atrioventricular 
(AV) node, establishing a direct connection between the atrium and the 
ventricle.1 The abnormality of embryological development of the heart 
during the differentiation of the cardiac fibrous skeleton which splits 
the atria and ventricles results in the existence of AP. Atrioventricular 
re-entrant tachycardia (AVRT) could be the re-entrant tachyarrhythmia 
that occurs in Wolff-Parkinson-White (WPW) syndrome.2 In AVRT, the 
existence of normal atrioventricular (AV) node and AP along with the 
atria and ventricles establishes the electrical circuit that permits 
impulse re-entry.3 The incidence of sudden cardiac death (SCD) in 
WPW syndrome is about 0.25% per year or 3% to 4% over a lifetime.4 
 In patients with WPW syndrome, the treatment of choice 
includes anti-arrhythmia drugs and radiofrequency ablation (RFA).5 
RFA is a safe, effective, and curative method, given its high individual 
efficacy.1 The RFA procedure is conducted based on the location of the 
AP, which could be predicted by 12-lead surface electrocardiogram 
(ECG).6 Prior information of the AP location permits better catheter 
ablation strategy such as (1) allowing the more appropriate choice of 
suitable energy sources and appropriate catheters; (2) more rapid and 
secure procedure; and (3) reduction of unnecessary vascular punctures 
and ionizing radiation exposure.1 Catheter ablation of anteroseptal and 
midseptal AP remains a challenginging procedure because of the 
anatomic proximity to the normal cardiac conduction system. 
Moreover, the catheter ablation procedure of septal AP has a higher 
recurrence rate and the chance for AV block.7–9 In present study, we 
reported our first experience in performing RFA for the accessory 
pathway located just below the Bundle of His.
2. Case Presentation
 A 69-year-old man was admitted for evaluation of frequent 
episodes of palpitation for three years before. He experienced palpita-
tion at rest or mild activity. Episodes of palpitation were more frequent 
in the last two months. He consumed bisoprolol 5 mg once daily and 
diltiazem 200 mg once daily. He did not have a history of chest pain or 
syncope previously. He was an active smoker, but he denied for taking 
alcohol. On admission, blood pressure was 140/90 mmHg, and pulse 
rate was 86 beats per minute regularly. There were no murmurs on 
cardiac auscultation. A 12-lead ECG showed sinus rhythm with heart 
rate 100 beats per minute, left axis deviation (LAD), short PR interval, 
and the existence of delta wave. The QRS complex and delta wave 
morphologies were negative in lead V1 and III; positive in the lead I, II, 
aVL, as well as lead V4-V6, indicating the AP was located in the 
anteroseptal position of the Bundle of His. A cardiothoracic ratio (CTR) 
55% was noted from the chest radiograph. Two-dimensional echocardi-
ography showed concentric left ventricular hypertrophy (LVH), LVEF 
64%, left ventricular (LV) diastolic dysfunction, and mild aortic regurgi-
tation (AR).  
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 The EP study was performed before the catheter ablation. We 
used three venous access at the femoral vein (6F and 7F introducer 
sheath) and one venous access at the jugular vein (6F introducer 
sheath). A decapolar catheter was advanced to the coronary sinus 
through jugular vein access. Through the femoral vein access, two 
quadripolar catheters were placed in the right ventricular apex (RVA) 
and Bundle of His, respectively, and one ablation catheter was placed 
in the high right atrium. We tried to induce the arrhythmia but failed 
after several attempts of aggressive pacing maneuver. Therefore, we 
decided to ablate the slow pathway. Resting ECG and electrogram  
showed anteroseptal AP, with AV fusion was shown at His catheter. 
Pacing from RVA also showed that VA fusion was noted at the His 
catheter. During the EP study, we performed cardiac mapping to 
identify the arrhythmia origin or areas of critical conduction to allow 
ablation targets. We decided to conduct catheter ablation with multiple 
RFA with maximum power 30 watts and temperature 40 degrees that 
delivered to the anteroseptal accessories pathway. During 20 minute 
observation, no fusion was noted at the Hiss catheter, and no recurrent 
episode of supraventricular tachycardia (SVT) was observed. Following 
that catheter ablation procedure, he never experienced the recurrent 
palpitation episodes.
3. Discussion
  WPW syndrome is characterized by the existence of the 
ventricular pre-excitation on the ECG and the event of paroxysmal 
tachycardia. Even though the AP is inherent, its first appearance can be 
occasionally identified in adolescence. The predominance of the 
tachyarrhythmia has been detailed to diminish with age in WPW 
syndrome.10 Even though its component is uncertain, a few degenera-
tive changes of the AP developing with age and guaranteeing prolonga-
tion of the effective refractory period (ERP) have been proposed. AVRT 
could be a re-entrant tachycardia that occurs in WPW syndrome. A 
normal AV node and an AP in conjunction with the atrium and ventri-
cles form a circuit permits re-entry impulse in AVNRT.8,10,11
 AP in the classical WPW Syndrome is varied in anatomic 
locations and conduction properties.6 Several algorithms had been 
established to predict the AP location.6,12,13 The conduction properties of 
AP could be from atria to the ventricles (antegrade), from the ventricles 
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Figure 1. (A) ECG before ablation revealed a short PR interval and the existence of the delta wave; (B) after ablation, there was no delta wave 
anymore. ECG = electrocardiogram.
(A)                                                                                                                (B)
Figure 2. EGM showed A-V Fusion at His distal. Catheter ablation with multiple RFA that delivered to the anteroseptal AP. After RFA to the 
anteroseptal AP, there was no fusion anymore. AP = accessory pathway; EGM = electrogram; RFA = radiofrequency ablation.
P. Lestari, et al. Heart Sci J 2020; 1(1): 26-29
 to the atria (retrograde), and also bidirectional.13,14 
 
Figure 3. Schematic representation of the atrioventricular annuli, the 
atrioventricular node (AVN), and the His bundle (HB). RA = Right 
Anterior; RAL = Right Anterolateral; RL = Right Lateral; RPL = Right 
Posterolateral; RP = Right Posterior; PSTA = Posteroseptal Tricuspid 
Annulus; CSOs = Coronary Sinus Ostium; MSTA = Midseptal Tricuspid 
Annulus; AS RAPS = anteroseptal tricuspid annulus and right anterior 
paraseptal; HB = His Bundle; PSMA= posteroseptal mitral annulus; LP 
= Left Posterior; LPL = Left Posterolateral; LL = Left Lateral; LAL = 
Left Anterolateral; CS = Coronary Sinus; MCV = Middle Cardiac Vein. 
(Source: modification from Daubert JP et al., 2019).
 The success rate of left-sided AP ablation is more than 90%. 
Technically, the catheter ablation procedure for right-sided AP is more 
challenging. Advancing the catheter to the proper position in the AV 
junction is difficult because of less stable catheter support. The utiliza-
tion of long sheaths to stabilize the catheter may be supportive.15 Since 
their closeness to the normal AV conduction system that will be harmed 
with ablation, the catheter ablation of anteroseptal AP is still challeng-
ing.13 Catheter ablation of the anteroseptal AP is generally showing 
poor success rates, high recurrence rates, and critical hazard of the 
complete AV block. The other difficulties of catheter ablation of 
anteroseptal AP are they are frequently located superficial and amena-
ble to catheter block during mapping. Those conditions can prolong the 
procedure time or lead to not successful results. The differences 
between anteroseptal AP need to be confirmed from right anterolateral 
or right anterior pathways, which can be ablated with low risk of AV 
node injury, and from the right mid-septal pathways, for which one 
should have an important concern with respect to compact AV node 
injury.16,17
 Traditionally, the catheter ablation of anteroseptal AP is 
performed through the inferior vena cava approach. Anteroseptal AP 
ablation may be unsuccessful because of conservative energy delivery at 
these locations or anatomical figures in some cases.18 An elective 
standard transfemoral approach with the catheter ablation position of 
anteroseptal AP through the cranial approach over the right internal 
jugular vein is frequently more stable with the approach through the 
superior vena cava. In most of anteroseptal AP, the ventricular end is 
located more lateral than the atrial end.19 We were optimistic that the 
catheter ablation procedure would be conducted successfully without 
any complications if the ablation catheter was placed at the save 
enough distance from the bundle of His.
 The management for WPW syndrome consists of pharmaco-
logic treatment and ablation. In our case, the AP was an anteroseptal 
pathway, and we decided to ablate it with multiple RFA. The challenge 
of this catheter ablation procedure was the risk of AV block because the 
target AP was located just below the bundle of His. After the follow-up 
period, a significant improvement was observed. The patient never 
complained of palpitation or any symptoms after catheter ablation.
4. Conclussion
  Radiofrequency catheter ablation therapy should be consid-
ered as the first-line treatment in the symptomatic patient, although 
there is a risk of AV block. In our case, we successfully ablate the 
accessory pathway without any complications.
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